Arthritis Clinical Trials in Los Angeles, CA

55 recruiting studies within 50 miles

Phase

Trial	Phase	Sponsor	Dist.
Innovations in Genicular Outcomes Registry	—	Pacira Pharmaceuticals, Inc	<1 mi
The Myelin Disorders Biorepository Project	—	Children's Hospital of Philadelphia	<1 mi
Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry	—	Duke University	<1 mi
MDR - Comprehensive Primary Revision Stems PMCF	—	Zimmer Biomet	<1 mi
RA-PRO PRAGMATIC TRIAL	Phase 3	University of Alabama at Birmingham	<1 mi
Study of Dapansutrile Tablets in Subjects With an Acute Gout Flare	Phase 2/3	Olatec Therapeutics LLC	<1 mi
Biologic Therapy to Prevent Osteoarthritis After ACL Injury	Early 1	University of California, Los Angeles	<1 mi
SMR Stemless Reverse Vs SMR Reverse Shoulder System	N/A	Limacorporate S.p.a	<1 mi
Study of GS-0272 in Participants With Rheumatoid Arthritis	Phase 1	Gilead Sciences	6 mi
Phase 1a/b Tolerability of NTR-1011 in Healthy Adults and Adult Patients With SLE and RA	Phase 1	Neutrolis	6 mi
Nipocalimab in Moderate to Severe Sjogren's Disease	Phase 3	Janssen Research & Development, LLC	7 mi
A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid Arthritis	Phase 2	AbbVie	9 mi
A Study to Assess Safety and Tolerability of PCRX-201 in Subjects With Painful Osteoarthritis of the Knee	Phase 2	Pacira Pharmaceuticals, Inc	9 mi
Safety and Feasibility of Umbilical Cord Wharton's Jelly Allograft Injections for Knee Osteoarthritis	Early 1	R3 Medical Research	9 mi
Safety and Feasibility of Umbilical Cord Wharton's Jelly Allograft Injections for Lumbar Pain	Phase 1	R3 Stem Cell	9 mi
A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)	Phase 4	Eli Lilly and Company	13 mi
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines	Phase 3	Takeda	13 mi
A Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly Throughout the Body Over Time in Adults	Phase 1	UCB Biopharma SRL	13 mi
Study of GS-0151 in Participants With Rheumatoid Arthritis	Phase 1	Gilead Sciences	13 mi
PREDICT Therapy Selection for JAK, T-cell, or IL-6 Inhibitor Therapies Using a Molecular Signature Response Classifier (PREDICT)	—	Scipher Medicine	13 mi
A Study of SPY072 in Rheumatic Disease	Phase 2	Spyre Therapeutics, Inc.	13 mi
ConsideRAte Study - Splenic Stimulation for RA	N/A	Galvani Bioelectronics	13 mi
A Biospecimen Collection Study to Identify the Targets of Disease-Reactive T Cells in Patients With Autoimmune Disease	—	TScan Therapeutics, Inc.	14 mi
A Study of Dotinurad Versus Allopurinol in Participants With Gout	Phase 3	Crystalys Therapeutics	14 mi
A Phase 2b/3a Study to Evaluate the Efficacy and Safety of JointStem in Patients Diagnosed as Knee Osteoarthritis	Phase 2/3	Nature Cell Co. Ltd.	14 mi
A Study to Evaluate the Effect of Bimekizumab on Gene Expression Biomarkers in Study Participants With Moderate to Severe Plaque Psoriasis	Phase 3	UCB Biopharma SRL	14 mi
A Study to Evaluate the Efficacy and Safety of Deucravacitinib in Adults With Active Sjögren's Syndrome	Phase 3	Bristol-Myers Squibb	14 mi
A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab)	Phase 1	UCB Biopharma SRL	14 mi
The Effect of Adipose-Derived Stem Cells for Knee Osteoarthritis	N/A	University of Colorado, Denver	14 mi
Genicular Artery Embolization Vs Observation for Symptomatic Knee Osteoarthritis	N/A	University of California, Los Angeles	14 mi
Treat-to-Target Serum Urate Versus Treat-to-Avoid Symptoms in Gout	Phase 4	Massachusetts General Hospital	14 mi
Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis and Anti-TNFα Inadequate Response	Phase 3	MoonLake Immunotherapeutics AG	14 mi
SakuraBead Used as Resorbable Embolic for Genicular Artery Embolization	N/A	CrannMed	16 mi
Long Term Evaluation of Safety and Efficacy of Tildrakizumab in Patients With Psoriatic Arthritis	Phase 3	Sun Pharmaceutical Industries Limited	17 mi
A Study to Investigate the Treatment Effect of Subcutaneous Injections of Pentosan Polysulfate Sodium Compared With Placebo in Adult Participants With Knee Osteoarthritis Pain.	Phase 3	Paradigm Biopharmaceuticals Ltd.	17 mi
A Clinical Study of Tulisokibart (MK-7240) to Treat Rheumatoid Arthritis (RA) (MK-7240-014)	Phase 2	Merck Sharp & Dohme LLC	18 mi
AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.	Phase 2	Artiva Biotherapeutics, Inc.	20 mi
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic Medicines	Phase 3	Takeda	20 mi
At-home Ultrasound Localized Therapy for Rheumatoid Arthritis Study [At-home ULTRA Study]	N/A	SecondWave Systems Inc.	20 mi
A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS)	Phase 3	Amgen	20 mi
Study Evaluating Safety, Tolerability, PK/PD of Surovatamig in Adult RA or SLE Participants	Phase 1	AstraZeneca	22 mi
A Study to Investigate Efficacy and Safety of AZD1163 in Participants With Rheumatoid Arthritis	Phase 2	AstraZeneca	25 mi
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight	Phase 3	Eli Lilly and Company	29 mi
Study of Targeted Therapies for the Treatment of Adult Participants With Active Psoriatic Arthritis	Phase 2	AbbVie	31 mi
A Study of Guselkumab Administered Subcutaneously in Bio-naive Participants With Active Psoriatic Arthritis Axial Disease	Phase 4	Janssen Research & Development, LLC	31 mi
A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Osteoarthritis (OA) of the Knee	Phase 3	Eli Lilly and Company	31 mi
An Adaptive Phase 2a/2b Study of LY3871801 in Adult Participants With Rheumatoid Arthritis	Phase 2	Eli Lilly and Company	31 mi
Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis Naive to Biologic Disease-Modifying Antirheumatic Drug	Phase 3	MoonLake Immunotherapeutics AG	34 mi
A Study to Assess the Efficacy and Safety of RO7790121 in Participants With Moderate to Severe Rheumatoid Arthritis Who Have Not Responded to or Who Cannot Tolerate Tumor Necrosis Factor (TNF) and/or Janus Kinase (JAK Inhibitors)	Phase 2	Hoffmann-La Roche	34 mi
Adipose-Derived Biocellular Regenerative Therapy for Osteoarthritis	N/A	Healeon Medical Inc	34 mi
Evaluating the Effect of Adipose Tissue Processed With the SyntrFuge™ System for Knee Osteoarthritis	N/A	Syntr Health Technologies, Inc.	36 mi
A Master Protocol Study (LY900028) of Multiple Intervention-Specific-Appendices (ISAs) in Participants With Chronic Pain	Phase 2	Eli Lilly and Company	36 mi
Zimmer Biomet Shoulder Arthroplasty PMCF	N/A	Zimmer Biomet	36 mi
Exactech Shoulder Post Market Clinical Follow-up Study	—	Exactech	43 mi
A Study to Evaluate the Drug Levels, Efficacy, and Safety of Deucravacitinib (BMS-986165) in Pediatric Participants With Juvenile Psoriatic Arthritis	Phase 3	Bristol-Myers Squibb	45 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.